Intent to Sole Source - Medrad Stellant Flex OCS Injection System

Special NoticeNo Set AsideActive

Key Takeaways

  • Set-aside for No Set Aside businesses
  • Work to be performed in Bethesda, MD
  • Industry: Surgical and Medical Instrument Manufacturing

Contract Details

Notice ID
NOI-OLAO-CC-26-009364
Opportunity Type
Special Notice
Sub-Agency
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH
Posted Date
Wednesday, September 16, 2026
Response Deadline
Saturday, September 26, 2026
PSC Code
6640
Set-Aside
No Set Aside
Place of Performance
Bethesda, MD, 20892
Status
Active

Description

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Bayer Healthcare LLC. Acquistion Description: The Center for Interventional Oncology in the Clinical Center/Radiology and Imaging Sciences and the National Cancer Institutes Center for Cancer Research conduct highly advanced research in dual layer spectral computed tomography (CT) imaging, developing new clinical applications. These ongoing studies require the injection of x-ray contrast under precisely controlled conditions, including timing, volume, and rate of injection. The specialized contrast injection system is integrated into the existing CT system and communicates with the

Why This Opportunity Matters

HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for surgical and medical instrument manufacturing with a set-aside for No Set Aside businesses in Bethesda, MD. This set-aside designation means eligible businesses face reduced competition from larger firms.